Default company panoramic image
D0087562 8a09 40c7 8501 1deb4851b4a5

Boston Therapeutics Inc.

The company just got the permission to submit PAZAMET as Abriviation New Drug Application with the FDA with no additional clinical trials.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded August 2009
  • Employees 7
  • Website bostonti.com

Company Summary

Boston Therapeutics Inc. develped an anti diabetic drug called PAZAMET and a food supplement called SUGARDOWN to prevent post meal elevation of blood glucose for pre diabetics and diabetics of 400,000,000 people world wide.

Team

Advisors

  • Default avatar
    Sayfart Shaw
    Lawyer
    Unconfirmed
    Default avatar
    Macladery
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Self funded
    Unconfirmed
    Default avatar
    100 individual investors
    Unconfirmed
    Default avatar
    Advance Pharmaceuticals Inc.
    Unconfirmed